Improving Vaccination Rates Among Adults and Young Adults
Myths, fears, distrust, and misinformation on immunizations can keep patients from benefiting from their protective effects.
Source: pharmacytimes.com
Expert Rev News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Expert Rev. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Expert Rev Today - Breaking & Trending Today
Ultra-Rare Inherited Bleeding Disorders: A Research Agenda for the Future
Investigators address 2 questions: How can we better understand the biology of these rare disorders? How can we stimulate research and optimize the regulatory process to improve diagnosis and targeted treatment?
Source: hcplive.com
Health Canada approves Takeda's LIVTENCITY™ (maribavir) the First and Only Treatment for Adults with Post-Transplant Cytomegalovirus (CMV) infection
TORONTO, Sept. 20, 2022 /CNW/ - Takeda Canada Inc. is pleased to announce that Health Canada has authorized LIVTENCITY™ for the treatment of adults with post-transplant cytomegalovirus ... | September 20, 2022
Source: marketscreener.com
Could there be a Salmonella Vaccine?
Salmonella is a mucosal pathogen that interacts with the host immune system; this interaction makes it an attractive target as an antigen delivery vector.
Source: news-medical.net
TissueTech Receives FDA Clearance to Proceed with Phase 1 Clinical Study using Investigational New Drug TTAX03 to Treat Facet Joint Osteoarthritis Pain
TissueTech Receives FDA Clearance to Proceed with Phase 1 Clinical Study using Investigational New Drug TTAX03 to Treat Facet Joint Osteoarthritis Pain Investigators will evaluate the dosage and safety of Cryopreserved Amniotic Membrane and Cryopreserved Umbilical Cord TTAX03 for pain relief and functional improvement of facet joint osteoarthritis in the lumbosacral region News provided by Share this article Share this article MIAMI, March 8, 2021 /PRNewswire/ -- Amniox Medical, Inc. (Amniox), a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue-based produ...
Source: prnewswire.com